Humana’s $2.8B CenterWell Deal Reframes Primary Care as Infrastructure

Humana is replacing WCAS with BlackRock’s HPS Investment Partners as the outside capital partner in a joint venture covering nearly 150 CenterWell Senior Primary Care clinics. The transaction values WCAS’s equity stake at approximately $2.8 billion.¹³

Announced October 13, the deal keeps CenterWell in charge of clinic operations while shifting majority ownership of the venture to BlackRock-affiliated capital. The structure positions Humana to keep expanding care delivery without carrying the full asset burden on its own balance sheet.¹³

The transaction is expected to close in the fourth quarter of 2026 and does not change Humana’s 2026 guidance, according to market reporting on the announcement.⁹ For healthcare business leaders, the significance is less the sponsor swap than the model it reinforces: insurers with large care-delivery ambitions may increasingly treat primary-care networks as capital-intensive infrastructure platforms, pairing payer strategy and operating control with third-party capital.

Humana keeps the operating lever

Under the new structure, HPS Investment Partners will replace Welsh, Carson, Anderson & Stowe as Humana’s joint-venture partner. BlackRock will hold a majority stake in the venture, while CenterWell will continue managing clinic operations.¹³ Adviser-side confirmation from Latham & Watkins also identifies BlackRock and HPS as the represented parties in the new strategic joint venture with Humana.⁴

That division of roles is central to the strategic logic. Humana is not exiting primary care delivery. It is retaining the clinic operating relationship, the clinical model and the strategic alignment with its Medicare Advantage business, while bringing in a capital partner better suited to finance a growing physical-care platform.⁵⁷

The formal securities filing adds another balance-sheet element: the deal removes the prior put option associated with the WCAS arrangement, is expected to reduce liabilities and gives CenterWell future purchase options tied to the venture.² In practical terms, Humana is reducing a financing overhang while preserving a path to regain ownership optionality later.

Why the structure matters

Primary care has become a strategic control point for Medicare Advantage insurers. Clinics can help manage risk, coordinate care, influence utilization and create more durable relationships with seniors. But building and owning clinics is capital intensive. Facilities, physicians, care teams, technology and local market expansion all require long-term investment before returns fully materialize.

The BlackRock-HPS deal points to a middle path. Humana can keep the strategic benefits of operating CenterWell clinics while funding growth through a partner that views the assets through an infrastructure and private-credit lens. Healthcare Dive framed the transaction around balance-sheet flexibility and growth capital, noting BlackRock’s majority stake in nearly 150 clinics.⁵ Fierce Healthcare similarly highlighted Humana’s goal of unlocking growth capital while maintaining CenterWell operations.⁷

That model may appeal to other payers and risk-bearing providers. Rather than owning every clinic outright, insurers can separate the operating platform from the asset-capital layer. The payer or care-delivery company keeps clinical and strategic control; the financial partner supplies long-duration capital and absorbs part of the ownership burden.

STAT characterized the deal as Humana swapping private-equity sponsors in a Medicare Advantage clinic network, with capital available for operations, new clinics and acquisitions.⁶ That captures the transaction’s immediate mechanics, but the broader implication is that primary-care networks are being financed more like scalable platforms than conventional provider subsidiaries.

The shift also reflects a maturing market. In earlier stages, payer-owned primary care was often discussed mainly as vertical integration: the insurer buys or builds the clinics, aligns incentives and captures more of the value chain. The Humana transaction suggests a more modular approach. Ownership, operations and financing can be separated and recombined as the network grows.

For Humana, that matters because CenterWell is both a care-delivery asset and a Medicare Advantage strategy. Keeping CenterWell as operator allows the company to preserve clinical continuity and alignment with its broader senior-care model, while the joint venture helps finance the clinics at what the company filing describes as a lower cost of capital.²

Balance-sheet flexibility becomes a care-delivery strategy

The deal also shows how capital structure is becoming part of healthcare strategy. Louisville Business First, covering the announcement from Humana’s home market, emphasized the liability-reduction and cost-of-capital rationale behind the new partnership.⁸ Those are not merely financial details. They can determine how quickly a clinic network can enter new markets, acquire practices or withstand pressure in Medicare Advantage margins.

For insurers, the trade-off is clear. Fully owning clinics offers maximum economics and control, but it ties up capital and exposes the company to real estate, labor and operating-cost risk. Joint ventures reduce that burden, but they require governance discipline and alignment with a financial partner whose return expectations may differ from the insurer’s care-management goals.

Humana’s structure attempts to preserve the part that matters most strategically: operating control. If CenterWell continues managing the clinics, Humana can keep directing the care model, patient experience and clinical integration while using outside capital to support scale.¹³

What to watch next

The first question is whether the transaction closes as expected in the fourth quarter of 2026 and whether the liability reduction outlined in Humana’s filing materializes as planned.²⁹ The second is whether Humana uses the new structure mainly to stabilize its balance sheet or to accelerate clinic expansion, acquisitions and market entry.

The third is whether competitors follow. Large insurers and risk-bearing provider groups face the same tension: primary care is strategically valuable, but building networks requires substantial capital. If Humana’s BlackRock-HPS partnership delivers lower financing costs without weakening operating control, similar structures could become more common across payer-owned and value-based care platforms.

The message for healthcare business leaders is straightforward. Primary care is no longer just an operating capability for insurers. It is becoming an investable infrastructure layer — one that can be owned, financed and scaled through structures that look increasingly like the rest of the alternative-asset market.

Humana’s $2.8B CenterWell Deal Reframes Primary Care as Infrastructure

More from Siften Business

Mexico’s expected Viva Aerobus-Volaris approval would hinge on fares, jobs and routes

Things to know

Comments

Source Material

Humana keeps the operating lever

Why the structure matters

Balance-sheet flexibility becomes a care-delivery strategy

What to watch next

Key topics covered

Jabil-Adani AI hardware pact tests India’s move up electronics value chain

Workday’s C1.ai Deal Makes Agent Identity a Control Point for Enterprise AI

LSEG’s Octus talks underscore the rising value of credit intelligence